Literature DB >> 23255794

Contribution of double-stranded RNA and CPSF30 binding domains of influenza virus NS1 to the inhibition of type I interferon production and activation of human dendritic cells.

Irene Ramos1, Elena Carnero, Dabeiba Bernal-Rubio, Christopher W Seibert, Liset Westera, Adolfo García-Sastre, Ana Fernandez-Sesma.   

Abstract

The influenza virus nonstructural protein 1 (NS1) inhibits innate immunity by multiple mechanisms. We previously reported that NS1 is able to inhibit the production of type I interferon (IFN) and proinflammatory cytokines in human primary dendritic cells (DCs). Here, we used recombinant viruses expressing mutant NS1 from the A/Texas/36/91 and A/Puerto Rico/08/34 strains in order to analyze the contribution of different NS1 domains to its antagonist functions. We show that the polyadenylation stimulating factor 30 (CPSF30) binding function of the NS1 protein from A/Texas/36/91 influenza virus, which is absent in the A/Puerto Rico/08/34 strain, is essential for counteracting these innate immune events in DCs. However, the double-stranded RNA (dsRNA) binding domain, present in both strains, specifically inhibits the induction of type I IFN genes in infected DCs, while it is essential only for inhibition of type I IFN proteins and proinflammatory cytokine production in cells infected with influenza viruses lacking a functional CPSF30 binding domain, such as A/Puerto Rico/08/34.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23255794      PMCID: PMC3571370          DOI: 10.1128/JVI.02247-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

Review 1.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.

Authors:  J Talon; C M Horvath; R Polley; C F Basler; T Muster; P Palese; A García-Sastre
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

4.  Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus.

Authors:  T Aragón; S de la Luna; I Novoa; L Carrasco; J Ortín; A Nieto
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

5.  Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.

Authors:  X Wang; M Li; H Zheng; T Muster; P Palese; A A Beg; A García-Sastre
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes.

Authors:  Idoia Burgui; Tomás Aragón; Juan Ortín; Amelia Nieto
Journal:  J Gen Virol       Date:  2003-12       Impact factor: 3.891

7.  Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication.

Authors:  M Bergmann; A Garcia-Sastre; E Carnero; H Pehamberger; K Wolff; P Palese; T Muster
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS.

Authors:  Diana L Noah; Karen Y Twu; Robert M Krug
Journal:  Virology       Date:  2003-03-15       Impact factor: 3.616

9.  Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins.

Authors:  Man-Seong Park; Megan L Shaw; Jorge Muñoz-Jordan; Jerome F Cros; Takaaki Nakaya; Nicole Bouvier; Peter Palese; Adolfo García-Sastre; Christopher F Basler
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  21 in total

1.  Functional Evolution of Influenza Virus NS1 Protein in Currently Circulating Human 2009 Pandemic H1N1 Viruses.

Authors:  Amelia M Clark; Aitor Nogales; Luis Martinez-Sobrido; David J Topham; Marta L DeDiego
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

2.  Uncompromised NK cell activation is essential for virus-specific CTL activity during acute influenza virus infection.

Authors:  Yuan Liu; Jian Zheng; Yinping Liu; Liyan Wen; Lei Huang; Zheng Xiang; Kwok-Tai Lam; Aizhen Lv; Huawei Mao; Yu-Lung Lau; Wenwei Tu
Journal:  Cell Mol Immunol       Date:  2017-04-17       Impact factor: 11.530

3.  The Nonstructural NS1 Protein of Influenza Viruses Modulates TP53 Splicing through Host Factor CPSF4.

Authors:  Manuel Rosa-Calatrava; Olivier Terrier; Julia Dubois; Aurélien Traversier; Thomas Julien; Blandine Padey; Bruno Lina; Jean-Christophe Bourdon; Virginie Marcel; Guy Boivin
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

4.  Changes in the NS1 gene of avian influenza viruses isolated in Thailand affect expression of type I interferon in primary chicken embryonic fibroblast cells.

Authors:  Chutamas Thepmalee; Phanchana Sanguansermsri; Naratchala Suwanankhon; Chanpen Chamnanpood; Pornchai Chamnanpood; Sutatip Pongcharoen; Pannika R Niumsap; Damratsamon Surangkul; Donruedee Sanguansermsri
Journal:  Indian J Virol       Date:  2013-08-28

5.  Viral Subpopulation Screening Guides in Designing a High Interferon-Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.

Authors:  Amir Ghorbani; Michael C Abundo; Hana Ji; Kara J M Taylor; John M Ngunjiri; Chang-Won Lee
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

Review 6.  Antiviral strategies against influenza virus: towards new therapeutic approaches.

Authors:  Arianna Loregian; Beatrice Mercorelli; Giulio Nannetti; Chiara Compagnin; Giorgio Palù
Journal:  Cell Mol Life Sci       Date:  2014-04-04       Impact factor: 9.261

7.  Influenza A Virus Utilizes Low-Affinity, High-Avidity Interactions with the Nuclear Import Machinery To Ensure Infection and Immune Evasion.

Authors:  Jaime Tome-Amat; Irene Ramos; Ferdinand Amanor; Ana Fernández-Sesma; Joseph Ashour
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

8.  Influenza A viruses balance ER stress with host protein synthesis shutoff.

Authors:  Beryl Mazel-Sanchez; Justyna Iwaszkiewicz; Joao P P Bonifacio; Filo Silva; Chengyue Niu; Shirin Strohmeier; Davide Eletto; Florian Krammer; Gene Tan; Vincent Zoete; Benjamin G Hale; Mirco Schmolke
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-07       Impact factor: 11.205

Review 9.  A Review and Meta-Analysis of Influenza Interactome Studies.

Authors:  Sonja Courtney Jun Hui Chua; Jianzhou Cui; David Engelberg; Lina Hsiu Kim Lim
Journal:  Front Microbiol       Date:  2022-04-21       Impact factor: 6.064

10.  Novel Bat Influenza Virus NS1 Proteins Bind Double-Stranded RNA and Antagonize Host Innate Immunity.

Authors:  Hannah L Turkington; Mindaugas Juozapaitis; Philip S Kerry; Teresa Aydillo; Juan Ayllon; Adolfo García-Sastre; Martin Schwemmle; Benjamin G Hale
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.